ROCHESTER, N.Y.--Last week, the U.S. Food and Drug Administration cleared Bausch & Lomb’s (NYSE: BOL) Nike Maxsight polymacon sport-tinted contact lens for market distribution. The soft contact lens, indicated for daily wear to correct refractive myopia and hyperopia, is designed to aid visual performance in athletic settings. Nike (NYSE: NKE) sought out B&L to partner in the development of the new sport-tinted CL three years ago, a B&L announcement said. In addition to co-development activities, B&L will manufacture the lens and market it to eyecare professionals; Nike will be responsible for consumer marketing
Bookmarks